Literature DB >> 23580158

A preliminary method development study to identify potential stroke biomarkers in plasma using multiple chromatographies with nanoLC-ESIMS detection.

Phanichand Kodali1, Julio A Landero-Figueroa, Joseph Caruso, Opeolu Adeoye.   

Abstract

Stroke is the leading cause of disability in the USA. Rapid, reliable diagnosis via a point-of-care blood test may facilitate earlier treatment to reduce disability. We have recently reported detailed methods of chromatographic separations of plasma samples coupled with nanoESI-ion trap a list of proteins which are viable candidates for further investigation as stroke biomarkers.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23580158      PMCID： PMC4739646          DOI： 10.1007/s00702-013-1018-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  30 in total

Review 1.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

2.  A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction.

Authors:  Michiaki Kubo; Jun Hata; Toshiharu Ninomiya; Koichi Matsuda; Koji Yonemoto; Toshiaki Nakano; Tomonaga Matsushita; Keiko Yamazaki; Yozo Ohnishi; Susumu Saito; Takanari Kitazono; Setsuro Ibayashi; Katsuo Sueishi; Mitsuo Iida; Yusuke Nakamura; Yutaka Kiyohara
Journal:  Nat Genet       Date:  2007-01-07       Impact factor: 38.330

Review 3.  Blood biomarkers in the diagnosis of ischemic stroke: a systematic review.

Authors:  William Whiteley; Mei-Chiun Tseng; Peter Sandercock
Journal:  Stroke       Date:  2008-07-24       Impact factor: 7.914

Review 4.  Blood markers for the prognosis of ischemic stroke: a systematic review.

Authors:  William Whiteley; Wei Li Chong; Anshuman Sengupta; Peter Sandercock
Journal:  Stroke       Date:  2009-03-12       Impact factor: 7.914

5.  Role of COL4A1 in small-vessel disease and hemorrhagic stroke.

Authors:  Douglas B Gould; F Campbell Phalan; Saskia E van Mil; John P Sundberg; Katayoun Vahedi; Pascale Massin; Marie Germaine Bousser; Peter Heutink; Jeffrey H Miner; Elisabeth Tournier-Lasserve; Simon W M John
Journal:  N Engl J Med       Date:  2006-04-06       Impact factor: 91.245

Review 6.  Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment.

Authors:  Amy K Saenger; Robert H Christenson
Journal:  Clin Chem       Date:  2009-11-19       Impact factor: 8.327

7.  Fibrinogen gene variation and ischemic stroke.

Authors:  K Jood; J Danielson; C Ladenvall; C Blomstrand; C Jern
Journal:  J Thromb Haemost       Date:  2008-03-07       Impact factor: 5.824

8.  Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.

Authors:  Gunnar Engström; Bo Hedblad; Lars Janzon; Folke Lindgärde
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-06

9.  Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites.

Authors:  Gerardo Alvarez-Manilla; James Atwood; Yan Guo; Nicole Lynn Warren; Ron Orlando; Michael Pierce
Journal:  J Proteome Res       Date:  2006-03       Impact factor: 4.466

10.  The 1425G/A SNP in PRKCH is associated with ischemic stroke and cerebral hemorrhage in a Chinese population.

Authors:  Lijun Wu; Yue Shen; Xin Liu; Xu Ma; Bo Xi; Jie Mi; Klaus Lindpaintner; Xuerui Tan; Xingyu Wang
Journal:  Stroke       Date:  2009-06-11       Impact factor: 7.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.